Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

60.0%

3 terminated/withdrawn out of 5 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05045092Withdrawn

A Follow-up Study of Neonates Receiving Extracorporeal Life Support in China

Role: collaborator

NCT05085080Withdrawn

Chinese Neonatal Extracorporeal Life Support Registry (Chi-NELS)

Role: collaborator

NCT05075486Not ApplicableWithdrawn

Quality Improvement to Reduce Mortality or Severe Intracranial Hemorrhage in Neonatal Extracorporeal Life Support

Role: collaborator

NCT05089760Unknown

Microbiology, Antimicrobial Resistance and Outcomes of Neonatal Sepsis in China

Role: collaborator

NCT02105051Unknown

A Population-based Investigation of Related Factors of Birth Weight in China

Role: lead

All 5 trials loaded